Annette Hasenburg Prof., Dr, med
Director, Obstetrics and Gynecology, Mainz University Medical Center, Mainz, GermanyBiographical Sketch:
Dr. Annette Hasenburg is the Director of Obstetrics and Gynecology at Mainz University Medical Center in Mainz, Germany. She is Head of the ESGO (European Society of Gynaecologic Oncology) Task Force Psycho-Oncology, and is on the board of directors of the Institute of Sexuality and Health of the University Freiburg in Freiburg, Germany.
Dr. Hasenburg received her medical degree from Ruhr-University, Bochum, Germany, where she also received residency training in internal medicine (Evangelisches Krankenhaus Herne) and obstetrics and gynecology (Marienhospital Herne). She received specialist training and qualification in psychotherapy at the Institute of Psychotherapy and Psychosomatic Medicine in Düsseldorf. She completed a postdoctoral fellowship in the Department of Obstetrics and Gynecology, Oncology Division, at Baylor College of Medicine in Houston, Texas.
Until joining the Mainz University Medical Center early in 2016, Dr. Hasenburg was Vice Chairman of the Department of Gynecology and Obstetrics and Associate Professor at the University of Freiburg School of Medicine.
Since 2018, Dr. Hasenburg has been on the Board of Directors of the AGO (Arbeitsgemeinschaft Gynäkologische Onkologie) and since 2020 on the Board of Directors of the DGGG (Deutsche Gesellschaft Gynäkologie und Geburtshilfe).
Positions:
Director, Obstetrics and Gynecology, Mainz University Medical Center, Mainz, Germany; Head, ESGO (European Society of Gynaecologic Oncology) Task Force Psycho-Oncology
Degrees:
Prof. Dr. med: Ruhr-University Bochum, Germany
Postgraduate Training:
Postdoctoral fellowship: obstetrics and gynecology, Oncology Division, Baylor College of Medicine, Houston, Texas
Qualification in Psychotherapy, Institute of Psychotherapy and Psychosomatic Medicine, Düsseldorf, Germany
Disclosures
Dr. Annette Hasenburg received honoraria from: AstraZeneca, Celgen, GSK, LEO Pharma, MedConcept GmbH, Med update GmbH, Medicultus, Pfizer, Promedicis GmbH, Softconsult, Roche Pharma AG, Streamedup!GmbH, Tesaro Bio Germany GmbH
She is in an advisory role for: AstraZeneca, GSK, LEO Pharma, PharmaMar, Promedicis GmbH, Roche Pharma AG, Tesaro Bio Germany GmbH, MSD Sharp&Dohme GmbH
Recent Contributions to PracticeUpdate:
- Adjuvant Chemotherapy Plus Radiation for Locally Advanced Endometrial Cancer
- ASCO 2019: Abstract Recommendations From Dr. Annette Hasenburg for Gynecologic Cancer
- Adjuvant Pelvic Radiation Therapy vs Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Risk Early-Stage Endometrial Cancer
- Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer
- Lymphadenectomy in Patients With Advanced Ovarian Neoplasms
- Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer
- Minimally Invasive vs Abdominal Radical Hysterectomy for Cervical Cancer
- ASCO 2018: Best in Ovarian Cancer
- ASCO 2018: Abstract Recommendations From Dr. Annette Hasenburg
- Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer